Richard N. Kender's Insider Trades & SAST Disclosures
Richard N. Kender's most recent trade in Seres Therapeutics Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard N. Kender.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 6,250 | 23,000 | - | 0 | Ordinary Shares | |
| Omega Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Longeveron Inc - Ordinary ... | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 1.46 per share. | 10 May 2024 | 16,000 | 16,000 | - | 1.5 | 23,280 | Class A Common Stock |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 6,000 | 16,750 | - | 0 | Ordinary Shares | |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 3.15 per share. | 05 Jul 2022 | 63,492 | 63,492 (0%) | 0% | 3.2 | 200,000 | COMMON STOCK |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Richard N. Kender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges